Thus, GPR39 may mediate depression development and progression both dependent and independent of its role as a zinc receptor and may begin to explain why targeting zinc levels alone, without concurrently targeting GPR39, has not consistently been successful in ameliorating depression or depression symptoms. The gene discussed is GPR39; the disease is depressive symptom measurement.